YH1 in Poorly Controlled Type 2 Diabetes

NCT02752880 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: YH1 group
DRUG: placebo group

Sponsor

Chang Gung Memorial Hospital